Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

LYELLYEL
3 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in LYELL IMMUNOPHARMA INC

Qube Research & Technologies Ltd holds 110,531 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $1.6M as of 2026-Q2. The position was increased (+100.6% shares). LYEL represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$1.6M

Current Shares

110,531

Total Value Change

+$1.3M

Total Shares Change

+101,480

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
110,531
+100.6%
$1.6M0.0%$14.05
41
2026-Q1
Increased
55,110
+508.9%
$1.1M0.0%$23.33
41
2025-Q4
New
9,051
-
$278,5900.0%$31.59
32

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used